In respiratory medicine overall, a growing body of applications already demonstrate the remarkable potential of AI to transform clinical practice 5,6 , This scoping review examines these developments in detail, identifies emerging opportunities for innovation, and considers the limitations and challenges that must be overcome to ensure AI is safe, effective, and can have an equitable integration into respiratory care
Panagis Galiatsatos, MD, MHS, assistant professor, division of pulmonary and critical care medicine, Johns Hopkins University School of Medicine, Baltimore, and national spokesman, American Lung Association, Chicago
That is probably the big factor that limits the acreage we can put into it, he says
This misidentification occurs when the body produces Immunoglobulin E (IgE) antibodies against specific allergens